[Research Progress in CircRNA and Radiotherapy Resistance of Non-small Cell Lung Cancer]

Overview

Journal Zhongguo Fei Ai Za Zhi

Specialties Oncology
Pulmonary Medicine

Date 2021 Nov 21

PMID 34802208

Authors

Weilong Li

Shenglin Ma

Shirong Zhang

Affiliations

Soon will be listed here.

Abstract

As the main type of lung cancer, non-small cell lung cancer (NSCLC) is a common cancer which is characterized by low 5-year survival rate and worse prognosis. Nowadays, some studies show that the low survival rate and worse prognosis are due to the resistance to radiotherapy caused by circRNA. Therefore, to find out the relationship between circRNA and radiotherapy resistance of NSCLC was imoprtant. According to research the relevant literatures, the relationship between circRNA and radiotherapy resistance of NSCLC was explored. CircRNA plays an important role in the invasion, metastasis, proliferation and treatment resistance of NSCLC. The radiation resistance of tumor cells induced by circRNA has become a crucial problem in radiotherapy. CircRNA plays an important role in the radiotherapy resistance of NSCLC. .

References

Chen R, Liu H, Yang L, Kang F, Xin L, Huang L . Circular RNA circRNA_0000285 promotes cervical cancer development by regulating FUS. Eur Rev Med Pharmacol Sci. 2019; 23(20):8771-8778. DOI: 10.26355/eurrev_201910_19271. View

Han W, Wang L, Zhang L, Wang Y, Li Y . Circular RNA circ-RAD23B promotes cell growth and invasion by miR-593-3p/CCND2 and miR-653-5p/TIAM1 pathways in non-small cell lung cancer. Biochem Biophys Res Commun. 2019; 510(3):462-466. DOI: 10.1016/j.bbrc.2019.01.131. View

Shi Y, Fang N, Li Y, Guo Z, Jiang W, He Y . Circular RNA LPAR3 sponges microRNA-198 to facilitate esophageal cancer migration, invasion, and metastasis. Cancer Sci. 2020; 111(8):2824-2836. PMC: 7419039. DOI: 10.1111/cas.14511. View

Cronin K, Lake A, Scott S, Sherman R, Noone A, Howlader N . Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics. Cancer. 2018; 124(13):2785-2800. PMC: 6033186. DOI: 10.1002/cncr.31551. View

Qin S, Zhao Y, Lim G, Lin H, Zhang X, Zhang X . Circular RNA PVT1 acts as a competing endogenous RNA for miR-497 in promoting non-small cell lung cancer progression. Biomed Pharmacother. 2018; 111:244-250. DOI: 10.1016/j.biopha.2018.12.007. View

Zhang T, Wu D, Deng S, Han R, Liu T, Li J . RNAseq profiling of circRNA expression in radiation-treated A549 cells and bioinformatics analysis of radiation-related circRNA-miRNA networks. Oncol Lett. 2020; 20(2):1557-1566. PMC: 7377113. DOI: 10.3892/ol.2020.11698. View

Li Y, Zhang J, Pan S, Zhou J, Diao X, Liu S . CircRNA CDR1as knockdown inhibits progression of non-small-cell lung cancer by regulating miR-219a-5p/SOX5 axis. Thorac Cancer. 2020; 11(3):537-548. PMC: 7049501. DOI: 10.1111/1759-7714.13274. View

Jiang M, Mai Z, Wan S, Chi Y, Zhang X, Sun B . Microarray profiles reveal that circular RNA hsa_circ_0007385 functions as an oncogene in non-small cell lung cancer tumorigenesis. J Cancer Res Clin Oncol. 2018; 144(4):667-674. DOI: 10.1007/s00432-017-2576-2. View

Ishihara S, Yasuda M, Ishizu A, Ishikawa M, Shirato H, Haga H . Activating transcription factor 5 enhances radioresistance and malignancy in cancer cells. Oncotarget. 2015; 6(7):4602-14. PMC: 4467102. DOI: 10.18632/oncotarget.2912. View

10.

Shen Z, Zhou L, Zhang C, Xu J . Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel. Cancer Lett. 2019; 468:88-101. DOI: 10.1016/j.canlet.2019.10.006. View

11.

Navarro-Martin A, Aso S, Cacicedo J, Arnaiz M, Navarro V, Rosales S . Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months. J Thorac Oncol. 2016; 11(7):1101-11. DOI: 10.1016/j.jtho.2016.03.021. View

12.

Jiang S, Wang R, Yan H, Jin L, Dou X, Chen D . MicroRNA-21 modulates radiation resistance through upregulation of hypoxia-inducible factor-1α-promoted glycolysis in non-small cell lung cancer cells. Mol Med Rep. 2016; 13(5):4101-7. DOI: 10.3892/mmr.2016.5010. View

13.

Li Y, Xu C, He C, Pu H, Liu J, Wang Y . circMTDH.4/miR-630/AEG-1 axis participates in the regulation of proliferation, migration, invasion, chemoresistance, and radioresistance of NSCLC. Mol Carcinog. 2019; 59(2):141-153. DOI: 10.1002/mc.23135. View

14.

Louis C, Desoteux M, Coulouarn C . Exosomal circRNAs: new players in the field of cholangiocarcinoma. Clin Sci (Lond). 2019; 133(21):2239-2244. DOI: 10.1042/CS20190940. View

15.

Yu D, Li Y, Ming Z, Wang H, Dong Z, Qiu L . Comprehensive circular RNA expression profile in radiation-treated HeLa cells and analysis of radioresistance-related circRNAs. PeerJ. 2018; 6:e5011. PMC: 6005163. DOI: 10.7717/peerj.5011. View

16.

Wei Y, Zhang Y, Meng Q, Cui L, Xu C . Hypoxia-induced circular RNA has_circRNA_403658 promotes bladder cancer cell growth through activation of LDHA. Am J Transl Res. 2019; 11(11):6838-6849. PMC: 6895513. View

17.

Wang L, Ma H, Kong W, Liu B, Zhang X . Up-regulated circular RNA VANGL1 contributes to progression of non-small cell lung cancer through inhibition of miR-195 and activation of Bcl-2. Biosci Rep. 2019; 39(6). PMC: 6549085. DOI: 10.1042/BSR20182433. View

18.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

19.

Zhang J, Li W . Long noncoding RNA CYTOR sponges miR-195 to modulate proliferation, migration, invasion and radiosensitivity in nonsmall cell lung cancer cells. Biosci Rep. 2018; 38(6). PMC: 6435535. DOI: 10.1042/BSR20181599. View

20.

Tang Y, Geng Y, Luo J, Shen W, Zhu W, Meng C . Downregulation of ubiquitin inhibits the proliferation and radioresistance of non-small cell lung cancer cells in vitro and in vivo. Sci Rep. 2015; 5:9476. PMC: 4377628. DOI: 10.1038/srep09476. View